Altrius Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Altrius Capital Management's LLY Position: Q2 2026 in Review
Altrius Capital Management reduced its Eli Lilly (LLY) stake by 3.8% in Q2 2026, selling an estimated $47K and leaving 1,173 shares worth $1.41M. The position accounts for 0.27% of the portfolio, ranked #70.
Altrius Capital Management first reported a position in LLY in Q2 2022 and has held it in 17 quarters since. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Altrius Capital Management held 1,173 shares of Eli Lilly worth $1.41M as of Q2 2026.
- Altrius Capital Management sold 46 Eli Lilly shares in Q2 2026, an estimated $47K.
- Eli Lilly made up 0.27% of Altrius Capital Management's portfolio in Q2 2026, its #70 holding.
- Altrius Capital Management first reported a position in Eli Lilly in Q2 2022 and has held it in 17 quarters since.
- 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Altrius Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.